Veterinary Point Of Care Diagnostics Market Report 2026

Veterinary Point Of Care Diagnostics Market Overview

• Veterinary Point Of Care Diagnostics market size has reached to $2.01 billion in 2025 • Expected to grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.3% • Growth Driver: Rising Companion Animal Population To Drive Market Growth • Market Trend: New Point-Of-Care Diagnostic Assay For Cushing’s Disease • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Point Of Care Diagnostics Market?

Veterinary point-of-care diagnostics are used for real-time animal health diagnostics, providing clinically meaningful information in clinical practice without relying on clinical laboratory results. It reduces the turnaround time (TAT) of animal test results for clinicians and patients in the prescribed treatment course. The main products of veterinary point of care diagnostics are consumables, reagents, kits and instruments and devices. The consumables, reagents and kits product of veterinary point of care diagnostics are products that are consumed, substances for preparing products, and test kits for diagnosis of both farm and companion animals. The veterinary point of care diagnostics are used for companion animals and livestock animals to cure infectious diseases and metabolic diseases by using technology such as immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other technologies that are used by veterinary clinics, veterinary hospitals and academic institutes, and home care settings.

What Is The Veterinary Point Of Care Diagnostics Market Growth Forecast?

The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to adoption of portable diagnostic analyzers, integration of AI and IoT in veterinary diagnostics, growth in home care veterinary solutions, increasing investment in veterinary point-of-care R&D, expansion of molecular and biochemical diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid diagnostic tools, rising demand for on-site testing solutions, expansion of companion animal health monitoring, integration of real-time data in veterinary care, growth of preventive veterinary diagnostics.

What Is The Driver Of The Veterinary Point Of Care Diagnostics Market?

The increasing companion animal population is expected to propel the veterinary point-of-care diagnostics market growth going forward. Companion animals are pets who share the residential area with humans. An increase in the companion animal population is increasing the demand for veterinary point-of-care diagnostics that enables faster clinical decision-making in the diagnostic, treatment selection and monitoring, and prognosis processes, as well as operational decision-making and resource utilization. Veterinary point of care diagnostics helps the increasing companion animal population by providing quick and accurate health assessments, enabling timely treatment and better overall care for pets. For instance, in March 2025, according to the American Pet Products Association, a US-based National Pet Products Trade Association, 94 million U.S. households owned at least one pet compared to 82 million in 2023, reflecting sharp growth in companion animal adoption. Therefore, the increasing companion animal population contributes to the veterinary point-of-care diagnostics market growth.

Key Players In The Global Veterinary Point Of Care Diagnostics Market

Major companies operating in the veterinary point of care diagnostics market are IDEXX Laboratories Inc., Heska Corporation, Eurolyser Diagnostica GmbH, Anipoc Ltd., Alvedia, Bionote Inc., Mindray Bio‑Medical Electronics Co. Ltd., Thermo Fisher Scientific Inc., BioGal Galed Labs, MEGACOR Diagnostik GmbH, GeneReach, Quidel Corporation, Biopanda Reagents Ltd., Biochek BV, IDvet, Skyla Corporation, Fassisi GmbH, GE Healthcare, Esaote SpA, BioMerieux SA, Prometheus Bio Inc., Midland BioProducts

Global Veterinary Point Of Care Diagnostics Market Trends and Insights

Major companies operating in the veterinary point-of-care diagnostics market are developing new assays to gain a competitive edge in the market. Assays refer to diagnostic procedures or tests designed to detect specific biological markers, substances, or conditions associated with a particular disease or health condition. For instance, in September 2023, Zomedica Corp., a US-based veterinary health company launched a new assay, endogenous ACTH (eACTH), for equine plasma on its TRUFORMA In-Clinic Biosensor Testing Platform. This development allows equine veterinarians to diagnose and manage Cushing's Disease (pituitary pars intermedia dysfunction - PPID) conveniently at the clinic or stall. The eACTH assay provides reference lab accuracy, aiding in the diagnosis and monitoring of horses with PPID, a common endocrine disorder in equines. Zomedica aims to address the unique needs of equine practitioners, promoting both patient and practice health with the TRUFORMA diagnostic platform.

What Are Latest Mergers And Acquisitions In The Veterinary Point Of Care Diagnostics Market?

In June 2023, Mars Incorporated, a US–based provider of pet nutrition, veterinary services, diagnostic solutions, and animal health care products, acquired Heska Corporation for an undisclosed amount. With this acquisition, Mars Petcare aimed to broaden access to veterinary diagnostics and technology, accelerate research and development, and expand its global point-of-care diagnostic capabilities within its Science & Diagnostics division, thereby strengthening its competitive position in the veterinary healthcare market. Heska Corporation is a US–based provider of veterinary point-of-care diagnostic instruments, in-clinic analyzers, consumables, and related diagnostic software solutions for companion animal veterinarians.

What Defines the Veterinary Point Of Care Diagnostics Market?

The veterinary point-of-care diagnostics market includes revenues earned by entities by hematology, diagnostic imaging, bacteriology, virology, cytology, clinical chemistry and parasitology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Point Of Care Diagnostics Market Report 2026?

The veterinary point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary point of care diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.